Mucosal Immunity in Diabetes

Mucosal immunity, the immune response at mucosal surfaces such as the gastrointestinal tract, plays an important role in regulating immune homeostasis and may influence the development of Type 1 Diabetes (T1D). The gut mucosal barrier interacts closely with the gut microbiome, and disturbances in this balance can contribute to immune dysregulation and autoimmunity. In T1D, gut-associated lymphoid tissue (GALT) and intestinal epithelial cells may be involved in triggering autoimmune responses against pancreatic beta cells. Additionally, impaired mucosal immunity can alter the gut microbiome composition, further promoting inflammation and increasing the risk of autoimmune diseases like T1D. Research into mucosal immunity in diabetes highlights the importance of gut health in regulating immune responses, offering potential therapeutic targets for modulating immune function and preventing disease progression.